DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025
BROSSARD, Quebec, Oct. 22, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI
(Financial Post, 2025-10-22T19:04:00Z)